Literature DB >> 2420924

Detection of scrapie-associated fibril (SAF) proteins using anti-SAF antibody in non-purified tissue preparations.

R Rubenstein, R J Kascsak, P A Merz, M C Papini, R I Carp, N K Robakis, H M Wisniewski.   

Abstract

Antisera raised to scrapie-associated fibril (SAF) proteins were used to detect scrapie-specific polypeptides in three different non-purified brain preparations: a synaptosomal-mitochondrial fraction, 20% brain homogenate and 20% brain homogenate extracted with Sarkosyl. The concentration of SAF proteins in the preparations was greater than the quantity of SAF as detected by negative stain electron microscopy. This suggests that not all of the protein exists in the form of SAF. An immunologically reactive 33K to 35K protein was detected in both normal and scrapie brain preparations. This protein was susceptible to complete proteinase K (PK) digestion in normal brain preparations and it is suggested that scrapie infection is responsible for post-translational modifications which confer PK resistance in scrapie preparations. These modifications may also play a role in the antigenic differences seen in a variety of scrapie agents. SAF-specific proteins were also detected in the spinal cords and spleens from scrapie-affected animals. Detergent extraction of material followed by PK treatment and Western blot analysis is a highly specific and sensitive method for the detection of SAF proteins. This procedure could be applied to human neurological diseases of unknown aetiology.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2420924     DOI: 10.1099/0022-1317-67-4-671

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  30 in total

1.  Neuropathological changes in scrapie and Alzheimer's disease are associated with increased expression of apolipoprotein E and cathepsin D in astrocytes.

Authors:  J F Diedrich; H Minnigan; R I Carp; J N Whitaker; R Race; W Frey; A T Haase
Journal:  J Virol       Date:  1991-09       Impact factor: 5.103

2.  Immunological comparison of scrapie-associated fibrils isolated from animals infected with four different scrapie strains.

Authors:  R J Kascsak; R Rubenstein; P A Merz; R I Carp; N K Robakis; H M Wisniewski; H Diringer
Journal:  J Virol       Date:  1986-09       Impact factor: 5.103

Review 3.  Prion liposomes.

Authors:  R Gabizon; S B Prusiner
Journal:  Biochem J       Date:  1990-02-15       Impact factor: 3.857

4.  Opposite effects of dextran sulfate 500, the polyene antibiotic MS-8209, and Congo red on accumulation of the protease-resistant isoform of PrP in the spleens of mice inoculated intraperitoneally with the scrapie agent.

Authors:  V Beringue; K T Adjou; F Lamoury; T Maignien; J P Deslys; R Race; D Dormont
Journal:  J Virol       Date:  2000-06       Impact factor: 5.103

5.  Immunological analysis of host and agent effects on Creutzfeldt-Jakob disease and scrapie prion proteins.

Authors:  J M Bockman; D T Kingsbury
Journal:  J Virol       Date:  1988-09       Impact factor: 5.103

6.  Immunohistochemical detection of prion protein in lymphoid tissues of sheep with natural scrapie.

Authors:  L J van Keulen; B E Schreuder; R H Meloen; G Mooij-Harkes; M E Vromans; J P Langeveld
Journal:  J Clin Microbiol       Date:  1996-05       Impact factor: 5.948

7.  Mouse polyclonal and monoclonal antibody to scrapie-associated fibril proteins.

Authors:  R J Kascsak; R Rubenstein; P A Merz; M Tonna-DeMasi; R Fersko; R I Carp; H M Wisniewski; H Diringer
Journal:  J Virol       Date:  1987-12       Impact factor: 5.103

8.  Improvement of PrPSc-detection in mouse spleen early at the preclinical stage of scrapie with collagenase-completed tissue homogenization and Sarkosyl-NaCl extraction of PrPSc.

Authors:  K U Grathwohl; M Horiuchi; N Ishiguro; M Shinagawa
Journal:  Arch Virol       Date:  1996       Impact factor: 2.574

9.  Pathogenic mutations within the hydrophobic domain of the prion protein lead to the formation of protease-sensitive prion species with increased lethality.

Authors:  Bradley M Coleman; Christopher F Harrison; Belinda Guo; Colin L Masters; Kevin J Barnham; Victoria A Lawson; Andrew F Hill
Journal:  J Virol       Date:  2013-12-18       Impact factor: 5.103

Review 10.  Inhibition of scrapie-associated PrP accumulation. Probing the role of glycosaminoglycans in amyloidogenesis.

Authors:  S A Priola; B Caughey
Journal:  Mol Neurobiol       Date:  1994 Apr-Jun       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.